Smoking in Irritable Bowel Syndrome: A Systematic Review

ABSTRACT Objective: The aim of this review was to examine (1) the prevalence of smoking in subjects with irritable bowel syndrome (IBS), (2) whether smoking prevalence significantly differs between subjects with and without IBS, and (3) whether smoking significantly predicts the presence or the development of IBS. Methods: Articles were retrieved by systematically searching the Scopus, Web of Science, and PubMed electronic databases from inception to July 2016, using the keywords “smoking” and “tobacco” combined with “irritable bowel syndrome.” Reference lists of included articles were also searched. Articles were included if they (1) reported data on smoking prevalence in subjects with IBS and/or on the association (assessed by means of multivariate analyses) between smoking and IBS, (2) identified IBS according to Manning criteria or Rome I–III criteria, (3) were English-language articles, and (4) involved only adult subjects. Results: The electronic searches yielded a total of 1,637 records, and 42 articles met inclusion criteria. Another 13 articles were retrieved through manual search, leading to a total of 55 included articles. Smoking prevalence in subjects with IBS was assessed by 48 articles and ranged from 0% in university students to 47.1% in patients with microscopic colitis. Thirty-three articles compared smoking prevalence between subjects with and without IBS. In 25 articles no significant difference was found. In seven articles smoking was significantly more frequent in subjects with IBS compared to those without IBS, while one study found a significantly higher smoking prevalence in controls. Eighteen multivariate analyses assessing the association between smoking and IBS were presented in 16 articles. Only one study employed a prospective design. In 11 analyses, smoking was not significantly associated with IBS after adjusting for covariates. In seven studies smoking independently predicted the presence of IBS. Conclusions: According to the selected articles, a significant association between smoking and IBS cannot be confirmed. However, different shortcomings may hinder generalizability and comparability of many studies. A dimensional assessment of smoking, a prospective design, the differentiation between IBS subgroups, and the recruitment of patients in clinical settings, especially in primary care, are necessary to clarify the role of smoking in IBS.

[1]  Lin Chang,et al.  FUNCTIONAL BOWEL DISORDERS , 2018, The American Journal of Gastroenterology.

[2]  U. Ghoshal,et al.  Frequency and risk factors of functional gastro‐intestinal disorders in a rural Indian population , 2017, Journal of gastroenterology and hepatology.

[3]  Ahmad Esmaillzadeh,et al.  Dietary patterns and prevalence of irritable bowel syndrome in Iranian adults , 2016, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[4]  B. Ohlsson,et al.  Smoking is associated with several functional gastrointestinal symptoms , 2016, Scandinavian journal of gastroenterology.

[5]  D. Drossman.  Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. , 2016, Gastroenterology.

[6]  S. Puli,et al.  Irritable Bowel Syndrome: A Clinical Review. , 2016, Current rheumatology reviews.

[7]  E. Quigley.  Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye? , 2016, Therapeutic advances in gastroenterology.

[8]  B. D. De Winter,et al.  Irritable bowel syndrome and visceral hypersensitivity : risk factors and pathophysiological mechanisms. , 2016, Acta gastro-enterologica Belgica.

[9]  T. Dinan,et al.  Stress and the Microbiota–Gut–Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome , 2016, CNS neuroscience & therapeutics.

[10]  T. Ohida,et al.  Irritable bowel syndrome among Japanese adolescents: A nationally representative survey , 2015, Journal of gastroenterology and hepatology.

[11]  M. El-Salhy.  Recent developments in the pathophysiology of irritable bowel syndrome. , 2015, World journal of gastroenterology.

[12]  A. Lucendo,et al.  Drug consumption and additional risk factors associated with microscopic colitis: Case-control study. , 2015, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[13]  Chia-Chi Wang,et al.  Clinical, metabolic, and psychological characteristics in patients with gastroesophageal reflux disease overlap with irritable bowel syndrome , 2015, European journal of gastroenterology & hepatology.

[14]  L. Öhman,et al.  Gut Microbiota as Potential Orchestrators of Irritable Bowel Syndrome , 2015, Gut and liver.

[15]  H. Park,et al.  The Effect of Emotional Stress and Depression on the Prevalence of Digestive Diseases , 2015, Journal of neurogastroenterology and motility.

[16]  R. Nagatomi,et al.  Staple Foods Consumption and Irritable Bowel Syndrome in Japanese Adults: A Cross-Sectional Study , 2015, PloS one.

[17]  Q. Zhan,et al.  Association between Diet and Lifestyle Habits and Irritable Bowel Syndrome: A Case-Control Study , 2014, Gut and liver.

[18]  M. Bijan,et al.  Psychological features in patients with and without irritable bowel syndrome: A case–control study using Symptom Checklist-90-Revised , 2015, Indian journal of psychiatry.

[19]  Norio Sugawara,et al.  Prevalence and Predictive Factors of Irritable Bowel Syndrome in a Community-dwelling Population in Japan. , 2015, Internal medicine.

[20]  Divyansh Bajaj,et al.  Epidemiology of Dyspepsia and Irritable Bowel Syndrome (IBS) in Medical Students of Northern India. , 2014, Journal of clinical and diagnostic research : JCDR.

[21]  N. Zhang,et al.  Association of anxiety disorders with the risk of smoking behaviors: a meta-analysis of prospective observational studies. , 2014, Drug and alcohol dependence.

[22]  R. Nagatomi,et al.  Irritable Bowel Syndrome Is Positively Related to Metabolic Syndrome: A Population-Based Cross-Sectional Study , 2014, PloS one.

[23]  Yanli Zhang,et al.  A School-Based Study of Irritable Bowel Syndrome in Medical Students in Beijing, China: Prevalence and Some Related Factors , 2014, Gastroenterology research and practice.

[24]  S. Shin,et al.  Incidence and predictive factors of irritable bowel syndrome after acute diverticulitis in Korea , 2014, International Journal of Colorectal Disease.

[25]  A. Pariente,et al.  Microscopic Colitis or Functional Bowel Disease With Diarrhea: A French Prospective Multicenter Study , 2014, The American Journal of Gastroenterology.

[26]  A. Masclee,et al.  Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to confounders , 2014, Alimentary pharmacology & therapeutics.

[27]  C. Cho,et al.  Cigarette smoking and gastrointestinal diseases: the causal relationship and underlying molecular mechanisms (review). , 2014, International journal of molecular medicine.

[28]  K. Whelan,et al.  Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect. , 2014, Journal of Crohn's & colitis.

[29]  S. Yao,et al.  A cross-sectional study of irritable bowel syndrome in nurses in China: prevalence and associated psychological and lifestyle factors , 2014, Journal of Zhejiang University-SCIENCE B.

[30]  P. Moayyedi,et al.  Characteristics of functional bowel disorder patients: a cross‐sectional survey using the Rome III criteria , 2014, Alimentary pharmacology & therapeutics.

[31]  B. Ohlsson,et al.  Smoking- and alcohol habits in relation to the clinical picture of women with microscopic colitis compared to controls , 2014, BMC Women's Health.

[32]  K. Sugano,et al.  Evidence-based clinical practice guidelines for irritable bowel syndrome , 2014, Journal of Gastroenterology.

[33]  A. Chawla,et al.  A Systematic Review of the Economic and Humanistic Burden of Illness in Irritable Bowel Syndrome and Chronic Constipation , 2013, Journal of managed care pharmacy : JMCP.

[34]  S. Nam,et al.  Irritable Bowel Syndrome Is Associated With Gastroesophageal Reflux Symptom but Not Erosive Esophagitis , 2013, Journal of neurogastroenterology and motility.

[35]  B. Ohlsson,et al.  Diarrhoea is not the only symptom that needs to be treated in patients with microscopic colitis. , 2013, European journal of internal medicine.

[36]  N. Naderi,et al.  Effects of Demographic Factors, Body Mass Index, Alcohol Drinking and Smoking Habits on Irritable Bowel Syndrome: A Case Control Study , 2013, Annals of medical and health sciences research.

[37]  P. Larsen,et al.  Patients Suspected of Irritable Bowel Syndrome—Cross-Sectional Study Exploring the Sensitivity of Rome III Criteria in Primary Care , 2013, The American Journal of Gastroenterology.

[38]  M. Prior,et al.  Irritable bowel syndrome with constipation: a European-focused systematic literature review of disease burden , 2013, Journal of medical economics.

[39]  N. Ibrahim,et al.  Prevalence and predictors of irritable bowel syndrome among medical students and interns in King Abdulaziz University, Jeddah , 2013, The Libyan journal of medicine.

[40]  V. Chong.  Irritable bowel syndrome among nurses and nursing students in Brunei Darussalam , 2013 .

[41]  G. Fava,et al.  The Unifying Concept of Illness Behavior , 2012, Psychotherapy and Psychosomatics.

[42]  T. Bernklev,et al.  Fatigue and disease-related worries among inflammatory bowel disease patients in remission; is it a reflection of coexisting IBS-like symptoms? A short report. , 2012, Journal of psychosomatic research.

[43]  W. Whitehead,et al.  Rome III survey of irritable bowel syndrome among ethnic Malays. , 2012, World journal of gastroenterology.

[44]  L. Bianchi,et al.  Current and past cigarette smoking significantly increase risk for microscopic colitis , 2012, Inflammatory bowel diseases.

[45]  R. Peto,et al.  Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys , 2012, The Lancet.

[46]  A. Ford,et al.  Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[47]  Michael Camilleri,et al.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[48]  H. Miwa.  Life style in persons with functional gastrointestinal disorders – large‐scale internet survey of lifestyle in Japan , 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[49]  S. Fereshtehnejad,et al.  Gender Role in Irritable Bowel Syndrome: A Comparison of Irritable Bowel Syndrome Module (ROME III) Between Male and Female Patients , 2012, Journal of neurogastroenterology and motility.

[50]  桂子 久米田,et al.  Prevalence of Irritable Bowel Syndrome and Its Relation to Lifestyle and Depression Quotient in a Japanese General Population , 2011 .

[51]  A. Gemignani,et al.  Evaluation of latent links between irritable bowel syndrome and sleep quality. , 2011, World journal of gastroenterology.

[52]  H. Moon,et al.  The Effects of Lifestyle Modification on Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: A Prospective Observational Study , 2011, Gut and liver.

[53]  N. Manek,et al.  Prevalence and Risk Factors of Gastrointestinal Disorders in Patients with Rheumatoid Arthritis: Results from a Population-Based Survey in Olmsted County, Minnesota , 2011, Gastroenterology research and practice.

[54]  S. Bolge,et al.  Health-related quality of life, work productivity and health care resource use associated with constipation predominant irritable bowel syndrome , 2011, Current medical research and opinion.

[55]  Stacey B. Daughters,et al.  Biological mechanisms underlying the relationship between stress and smoking: State of the science and directions for future work , 2011, Biological Psychology.

[56]  M. Myśliwiec,et al.  Factors associated with irritable bowel syndrome symptoms in hemodialysis patients. , 2011, World journal of gastroenterology.

[57]  K. Tominaga,et al.  Differences between risk factors among irritable bowel syndrome subtypes in Japanese adults , 2011, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[58]  B. Spiegel,et al.  The effect of irritable bowel syndrome on health-related quality of life and health care expenditures. , 2011, Gastroenterology clinics of North America.

[59]  A. Ford,et al.  Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review , 2011, Journal of Gastroenterology.

[60]  M. Salehi,et al.  Irritable bowel syndrome in adults over 35 years in Shiraz, southern Iran: prevalence and associated factors , 2011, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[61]  K. Tominaga,et al.  Cigarette smoking and its association with overlapping gastroesophageal reflux disease, functional dyspepsia, or irritable bowel syndrome. , 2011, Internal medicine.

[62]  P. Vandvik,et al.  How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice , 2010, BMC gastroenterology.

[63]  B. Afşar,et al.  Irritable bowel syndrome in haemodialysis: Prevalence, link with quality of life and depression , 2010, Nephrology.

[64]  D. Drossman,et al.  Validation of Symptom-Based Diagnostic Criteria for Irritable Bowel Syndrome: A Critical Review , 2010, The American Journal of Gastroenterology.

[65]  A. Zinsmeister,et al.  Impact of Functional Gastrointestinal Disorders on Survival in the Community , 2010, The American Journal of Gastroenterology.

[66]  S. Nam,et al.  Prevalence and Risk Factors of Irritable Bowel Syndrome in Healthy Screenee Undergoing Colonoscopy and Laboratory Tests , 2010, Journal of neurogastroenterology and motility.

[67]  A. Bruno,et al.  Depression, Anxiety and Anger in Subtypes of Irritable Bowel Syndrome Patients , 2010, Journal of Clinical Psychology in Medical Settings.

[68]  P. Robson,et al.  Smoking frequency, prevalence and trends, and their socio-demographic associations in Alberta, Canada. , 2009, Canadian journal of public health = Revue canadienne de sante publique.

[69]  P. Whorwell,et al.  Irritable bowel syndrome in the elderly: An overlooked problem? , 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[70]  Hyojin Park,et al.  The Clinical Course of Postinfectious Irritable Bowel Syndrome: A Five-year Follow-up Study , 2009, Journal of clinical gastroenterology.

[71]  A. Zinsmeister,et al.  Psychosocial Distress and Somatic Symptoms in Community Subjects With Irritable Bowel Syndrome: A Psychological Component Is the Rule , 2009, The American Journal of Gastroenterology.

[72]  Sung Won Cho,et al.  Prevalence and Risk Factors for Overlaps between Gastroesophageal Reflux Disease, Dyspepsia, and Irritable Bowel Syndrome: A Population-Based Study , 2009, Digestion.

[73]  M. Lindström,et al.  Gender differences in daily smoking prevalence in different age strata: A population-based study in southern Sweden , 2009, Scandinavian journal of public health.

[74]  M. Hongo,et al.  High Prevalence of Irritable Bowel Syndrome in Medical Outpatients in Japan , 2008, Journal of clinical gastroenterology.

[75]  A. Daley,et al.  The Effects of Exercise upon Symptoms and Quality of Life in Patients Diagnosed with Irritable Bowel Syndrome: A Randomised Controlled Trial , 2008, International journal of sports medicine.

[76]  A. Zinsmeister,et al.  Overlap of gastro‐oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population , 2007, Alimentary pharmacology & therapeutics.

[77]  Toku Takahashi,et al.  Sex differences in irritable bowel syndrome in Japanese university students , 2006, Journal of Gastroenterology.

[78]  J. Barton,et al.  Factors associated with the development of post-infectious functional gastrointestinal diseases: does smoking play a role? , 2005, European journal of gastroenterology & hepatology.

[79]  E. Quigley.  Disturbances of motility and visceral hypersensitivity in irritable bowel syndrome: biological markers or epiphenomenon. , 2005, Gastroenterology clinics of North America.

[80]  J. Keller,et al.  The perceived effect of various foods and beverages on stool consistency , 2005, European journal of gastroenterology & hepatology.

[81]  N. Talley,et al.  Review article: the overlap between functional dyspepsia and irritable bowel syndrome — a tale of one or two disorders? , 2004, Alimentary pharmacology & therapeutics.

[82]  R. Brummer,et al.  Irritable bowel syndrome in general practice: an overview , 2004, Scandinavian journal of gastroenterology. Supplement.

[83]  E. Blanchard,et al.  Psychopathology in Irritable Bowel Syndrome: Support for a Psychophysiological Model , 2003, Journal of Behavioral Medicine.

[84]  K. Goh,et al.  Prevalence of irritable bowel syndrome in young adult Malaysians: A survey among medical students , 2003, Journal of gastroenterology and hepatology.

[85]  H. McRobbie,et al.  Stopping smoking can cause constipation. , 2003, Addiction.

[86]  Nuri Karaman,et al.  Irritable bowel syndrome prevalence in city center of Sivas. , 2003, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[87]  Prabhat Jha,et al.  Estimates of global and regional smoking prevalence in 1995, by age and sex. , 2002, American journal of public health.

[88]  I. Wiklund,et al.  Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials , 2001, Alimentary pharmacology & therapeutics.

[89]  N. Talley,et al.  Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: A critical review of the literature on symptom and psychosocial factors , 2001, American Journal of Gastroenterology.

[90]  G. Thomas,et al.  Role of smoking in inflammatory bowel disease: implications for therapy , 2000, Postgraduate medical journal.

[91]  L. Melton,et al.  Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities , 2000, American Journal of Gastroenterology.

[92]  G. Bodemar,et al.  Division of the irritable bowel syndrome into subgroups on the basis of daily recorded symptoms in two outpatients samples. , 1999, Scandinavian journal of gastroenterology.

[93]  K W Heaton,et al.  Functional bowel disorders and functional abdominal pain , 1999, Gut.

[94]  C. Beglinger,et al.  Effect of transdermal application of nicotine on colonic transit in healthy nonsmoking volunteers , 1998, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[95]  J. Muris,et al.  The clinical course and prognostic determinants of the irritable bowel syndrome: a literature review. , 1998, Scandinavian journal of gastroenterology.

[96]  L. Melton,et al.  Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. , 1995, American journal of epidemiology.

[97]  P. Bedossa,et al.  Cirrhosis as an independent risk factor for colonic adenomas. , 1992, Gut.

[98]  D. Drossman,et al.  Identification of sub-groups of functional gastrointestinal disorders , 1990 .

[99]  Y. Katayama.  Bowel disorders. , 1990, Postgraduate medicine.

[100]  P. Openshaw,et al.  Towards positive diagnosis of the irritable bowel. , 1978, British medical journal.